Спорообразующие пробиотики и их применение у детей
DOI:
https://doi.org/10.15574/SP.2015.68.77Аннотация
Обобщены данные литературы о спорообразующих пробиотиках, а также опыт их использования при патологии желудочно-кишечного тракта у детей. Анализ приведенных данных позволяет рекомендовать применение препарата «Биоспорин-Биофарма» как в целях профилактики, так и в комплексной терапии заболеваний желудочно-кишечного тракта на всех уровнях оказания медицинской помощи детям, в том числе раннего возраста.
Ключевые слова: спорообразующие пробиотики, дети, препарат «Биоспорин-Биофарма».
Библиографические ссылки
Korniychuk OP, Burova LM, Lavrik GS et al. 2013. Biosporin antimicrobial activity: study in vitro. Sovremennaya pediatriya. 6(55): 61—66.
Korneva VV, Kozachuk VG, Boyarskaya EA et al. 2014. The top features of chronic constipation among children and possible ways to resolve them. Sovremennaya pediatriya. 5(61): 128—135.
Darmov IV, Chicherin IYu, Pogorelskiy IP i dr. 2013. Vyizhivaemost mikroorganizmov probiotikov v zheludochno-kishechnom trakte eksperimentalnyih zhivotnyih. Kishechnaya mikroflora (Innovatsionnyiy sbornik nauchnyih statey). 2: 31—35.
Darmov IV, Chicherin IYu, Pogorelskiy IP i dr. 2012. Vyizhivaemost mikroorganizmov probiotikov v zheludochno-kishechnom trakte eksperimentalnyih zhivotnyih. Zhurn infektol. 4;1: 68—74.
Darmov IV, Chicherin IYu, Pogorelskiy IP, Lundovskih IA. 2011. Vyizhivaemost mikroorganizmov probiotikov v usloviyah in vitro, imitiruyuschih protsess pischevareniya u cheloveka. Eksperiment i klin gastroenterol. 3: 6—11.
Germanenko IG. 2014. Disbakterioz kishechnika u detey. Mezhdunar obzoryi: klin. praktika i zdorove. 2: 67—72.
Chicherin IYu, Darmov IV, Pogorelskiy IP i dr. 2013. Zamestitelnoe deystvie probiotikov: mif ili realnost. Kishechnaya mikroflora (Innovatsionnyiy sbornik nauchnyih statey). 2: 8—11.
Yakovenko EP, Anikina EV, Yakovenko AV i dr. 2014. Innovatsionnyie mnogovidovyie multishtammovyie probiotiki v klinicheskoy praktike. Lechaschiy vrach. 5: 15—212.
Korneva VV, Kozachuk VG, Boyarskaya EA, Kapichina MA. 2010. Biosporin-Biopharm usage in the treatment of chronic constipations at children. Sovremennaya pediatriya. 3(31): 108—113.
Kalyuzhin OV. 2012. Probiotiki kak sovremennyie sredstva ukrepleniya protivoinfektsionnoy immunnoy zaschityi: mif ili realnost? RMZh. 28: 1395—1402.
Sorokulova IB, Safronova LA, Vinogradov VP i dr. 2008. Korrektsiya biosporinom narusheniy mikrobiotsenoza kishechnika u novorozhdennyih detey (kratkoe soobschenie). Ros vestn perinat i pediatrii. 5: 17—19.
Kostyukevich OI. 2011. Vliyanie kishechnoy mikrofloryi na zdorove cheloveka. Ot patogeneza k sovremennyim metodam korrektsii disbioza. RMZh. 5: 304—309.
Lezhenko HO, Pashkova OIe. 2014. Dosvid zastosuvannia preparatu Biosporyn-Biofarma v korektsii funktsionalnykh rozladiv shlunkovo-kyshkovoho traktu u ditei hrudnoho viku. Zdorove rebenka. 8;7: 7—10.
Marushko RV, Marushka TL. 2015. Effectiveness of preparation Biosporin-Biopharma in infants with intestinal dysbiosis. Sovremennaya pediatriya. 2(66): 77—83. doi 10.15574/SP.2015.66.77
Marushko RV, Marushko TL. 2014. Implications of probiotics in the treatment on functional bowel diseases in infants. Sovremennaya pediatriya. 7(63): 106—113. doi 10.15574/SP.2014.63.106
Marushko RV, Marushko T L. 2014. Effectiveness of probiotic containing bacillus subtilis and bacillus licheniformis in infants with bowel diseases. Sovremennaya pediatriya. 8(64): 90—98.
Pohilenko VD, Perelyigin VV. 2007. Probiotiki na osnove sporoobrazuyuschih bakteriy i ih bezopasnost. Himich i biologich bezopasnost. 2—3: 32—33.
Legeza K. N., Chaplinskyi V. Y., Sorokulova I. B. et al. 2013. Application of Biosporinat during the treatment of intestinal infections. Sovremennaya pediatriya. 5: 172—174.
Psahis IB, Makovskaya TE. 2014. Sovremennyie vozmozhnosti i perspektivyi ispolzovaniya probiotikov gruppyi samoeliminiruyuschihsya antagonistov v terapii infektsionnyih zabolevaniy. Zdorove rebenka. 55;4: 91—95.
Safonova MA, Kuznetsov OYu. 2012. Probioticheskie preparatyi dlya korrektsii mikro ekologicheskih narusheniy kishechnika. Vestn Ivanovskoy med akad. 17;1: 49—54.
Skryipnik IN, Maslova AS. 2009. Sovremennyie cporoobrazuyuschie probiotiki v klinicheskoy praktike. Such gastroenterol. 3(47): 81—90.
Osipova IG, Mihaylova NA, Sorokulova IB et al. 2003. Sporovyie probiotiki. Zhurn mikrobiol. 3: 113—119.
Darmov IV, Chicherin IYu, Pogorelskiy IP et al. 2012. Sravnitelnaya otsenka vyizhivaemosti mikroorganizmov probiotikov v sostave kommercheskih preparatov v usloviyah in vitro. Kishechnaya mikroflora. Sb nauch st. 1: 11—15.
Ursova NI. 2009. Narusheniya funktsii zheludochno_kishechnogo trakta u detey rannego vozrasta: problema, analiz obobschennyih dannyih. Sovremennaya pediatriya Sovr pediatriya. 6(28): 48—54.
Uspenskiy YuP, Zaharenko SM, Fominyih YuA. 2013. Perspektivyi ispolzovaniya multividovyih probiotikov dlya profilaktiki razvitiya antibiotik-assotsiirovannoy diarei. Eksperiment i klin gastroenterol. 2: 54—56.
Shumilov PV. 2010. Nereshennyie voprosyi patogeneza vospalitelnyih zabolevaniy kishechnika u detey. Rol pristenochnoy mikrofloryi kishechnika. Pediatrich farmakol. 7;5: 54—58.
Hong HA, Khaneja R, Tam NM et al. 2009. Bacillus subtilis isolated from the human gastrointestinal tract. Res Microbiol. 160;2: 134—143.
Bader J, Albin A, Stahl U. 2012. Spore_forming bacteria and their utilisation as probiotics. Benef Microbes. 3;1: 67—75.
Morgan XC, Tickle TL, Sokol H et al. 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13;9: 79.
Selvam R, Maheswari P, Kavitha P et al. 2009. Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease. Indian J Biochem Biophys. 46;1: 79—85.
Ford AC, Quigley EM, Lacy BE et al. 2014. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 109;10: 1547—1561.
Guandalini S, Cernat E, Moscoso D. 2014. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Benef Microbes. 12: 1—9.
Hong HA, le Duc H, Cutting SM. 2004.The use of bacterial spore formers as probiotics. FEMS Microbiol Rev. 29;4: 813—835.
Tejero-Sarinena, Barlow J, Costabile A et al. 2014. In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: Evidence for the effects of organic acids. Anaerobe. 18;5: 530—538.
Tojo R, Suarez A, Clemente MG et al. 2014. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J Gastroenterol. 20;41: 15163—15176.
Saulnier DMA, Spinler KJ, Gibson GR et al. 2009. Mechanisms of Probiosis and Prebiosis: Considerations for Enhanced Functional Foods. Curr Opin Biotechnol. 20;2: 135—141.
Mongkolthanaruk W. 2012. Classification of Bacillus beneficial substances related to plants, humans and animals. J Microbiol Biotechnol. 22;12: 1597—1604.
Chiu YH, Lin SL, Tsai JJ, Lin MY. 2014. Probiotic actions on diseases: implications for therapeutic treatments. Food Funct. 5;4: 625—634.
Foligne B, Peys E, Vandenkerckhove J et al. 2012. Spores from two distinct colony types of the strain Bacillus subtilis PB6 substantiate anti-inflammatory probiotic effects in mice. Clin Nutr. 31;6: 987—994.
Suvorov A. 2013. Gut microbiota, probiotics, and human health. Biosci Microbiota Food Health. 32;3: 81—91.
Fujiya M, Musch MW, Nakagawa Y et al. 2007. The Bacillus subtilis quorum_sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe. 1;4: 299—308.
Sorokulova IB, Pinchuk IV, Denayrolles M et al. 2008. The safety of two Bacillus probiotic strains for human use. Dig Dis Sci. 53;4: 954—963.
Round JL, Lee SM, Li J et al. 2011. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 332: 974—977.
Urdaci MC, Bressollier P, Pinchuk I. 2004. Bacillus clausii probiotic strains: antimicrobial and immunomodulatory аctivities. J Clin Gastroenterol. 38;6: 86—90.
Williams P. 2007. Bacillus subtilis: a shocking message from a probiotic. Cell Host Microbe. 1;4: 248—249.
Williams P. 2007. Quorum sensing, communication and cross-kingdom signaling in the bacterial world. Microbiology. 153: 3923—3938.
